Data Opts Intern, Pison

The company provides technology that allows ALS patients to interact with wearable devices and control the physical world through thinking alone. With development partners including Google, Microsoft, and Samsung, the system captures neuromuscular signals on the surface of the skin and combines them with machine learning and AI to interpret how people intend to move their hands.

Pison has raised money both through grants and traditional investment rounds, closing its Series A in 2021. This funding is being used to develop multiple market-ready products including wearables and data analysis platforms for non-medical purposes, and to increase the company’s headcount.